Tackling COVID-19
As we stay apart, pharmaceutical companies are coming together to fight against COVID-19
LEARN MOREIntellectual Property
Europe’s framework of incentives and rewards for discovering and developing new treatments deliver access to today’s medicines and investment into tomorrow’s cures for patients who need them.
LEARN MORE
Help us make rare disease even rarer
Only 8 OMP medicines existed in 2000, before the EU Regulation came in to force, compared to 184 today.
LEARN MORE
Relationships and Code
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals
LEARN MORE
Latest Updates
VIEW ALL-
Statements & press releases 27.10.21
Good Lay Summary Practice Recommendations are now published in EudraLex.
Recognising the importance of providing accessible and understandable summaries of clinical trial results to patients and the interested public.
Read Article -
Blog articles 27.10.21
Fitting vaccine research into one year – Were animals used?
A blog by EFPIA and Vaccines Europe
Read Article -
Blog articles 15.10.21
The future of healthcare is systematic digitization and unification of data (Guest blog)
Takeaways from The Value of Innovation conference
Read Article -
External Events 19.11.21
Estimands from trial planning to publication in medical journals: The ETHOS trial
PSI EIWG is delighted to invite you to join this Webinar
View Event -
External Events 29.11.21
Clinical Trial Disclosure & Data Transparency Conference
Evolving Requirements and New Challenges
View Event -
External Events 10.02.22
10th ACCELERATE Paediatric Oncology Conference
Save the Date!
View Event
Featured Articles
Featured event
Accelerating Adoption of Complex Clinical Trials in Europe and beyond
A multi-stakeholder workshop to develop shared solutions for the use of complex clinical trials to optimise drug development in Europe
View Event